YU45793B - Postupak za dobijanje stabilnih kristalnih adicionih soli 7-/alfa-(2-aminotiazola-4-il)-alfa-(z)-metoksiimino acetamido/-3-/(1-metil-1-pirolidino)-metil/-3-cefem-karboksilata sa kiselinama, kao i preparata koji ih sadrže - Google Patents

Postupak za dobijanje stabilnih kristalnih adicionih soli 7-/alfa-(2-aminotiazola-4-il)-alfa-(z)-metoksiimino acetamido/-3-/(1-metil-1-pirolidino)-metil/-3-cefem-karboksilata sa kiselinama, kao i preparata koji ih sadrže

Info

Publication number
YU45793B
YU45793B YU137186A YU137186A YU45793B YU 45793 B YU45793 B YU 45793B YU 137186 A YU137186 A YU 137186A YU 137186 A YU137186 A YU 137186A YU 45793 B YU45793 B YU 45793B
Authority
YU
Yugoslavia
Prior art keywords
alpha
methyl
aminothiazola
pyrolidino
cefem
Prior art date
Application number
YU137186A
Other languages
English (en)
Serbo-Croatian (sh)
Other versions
YU137186A (en
Inventor
M.A. Kaplan
T.W. Hudyma
R.A. Lipper
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of YU137186A publication Critical patent/YU137186A/xx
Publication of YU45793B publication Critical patent/YU45793B/sh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
YU137186A 1985-08-05 1986-07-31 Postupak za dobijanje stabilnih kristalnih adicionih soli 7-/alfa-(2-aminotiazola-4-il)-alfa-(z)-metoksiimino acetamido/-3-/(1-metil-1-pirolidino)-metil/-3-cefem-karboksilata sa kiselinama, kao i preparata koji ih sadrže YU45793B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76223585A 1985-08-05 1985-08-05

Publications (2)

Publication Number Publication Date
YU137186A YU137186A (en) 1987-12-31
YU45793B true YU45793B (sh) 1992-07-20

Family

ID=25064475

Family Applications (1)

Application Number Title Priority Date Filing Date
YU137186A YU45793B (sh) 1985-08-05 1986-07-31 Postupak za dobijanje stabilnih kristalnih adicionih soli 7-/alfa-(2-aminotiazola-4-il)-alfa-(z)-metoksiimino acetamido/-3-/(1-metil-1-pirolidino)-metil/-3-cefem-karboksilata sa kiselinama, kao i preparata koji ih sadrže

Country Status (34)

Country Link
JP (1) JPH0615548B2 (cg-RX-API-DMAC7.html)
KR (1) KR930003121B1 (cg-RX-API-DMAC7.html)
AR (1) AR243894A1 (cg-RX-API-DMAC7.html)
AT (1) AT390957B (cg-RX-API-DMAC7.html)
AU (1) AU597262B2 (cg-RX-API-DMAC7.html)
BE (1) BE905219A (cg-RX-API-DMAC7.html)
CA (1) CA1284994C (cg-RX-API-DMAC7.html)
CH (1) CH675581A5 (cg-RX-API-DMAC7.html)
CS (2) CS276849B6 (cg-RX-API-DMAC7.html)
CY (1) CY1614A (cg-RX-API-DMAC7.html)
DD (2) DD254941A5 (cg-RX-API-DMAC7.html)
DE (1) DE3626375A1 (cg-RX-API-DMAC7.html)
DK (1) DK162053C (cg-RX-API-DMAC7.html)
EG (1) EG18003A (cg-RX-API-DMAC7.html)
ES (1) ES2002112A6 (cg-RX-API-DMAC7.html)
FI (1) FI84484C (cg-RX-API-DMAC7.html)
FR (1) FR2585705B1 (cg-RX-API-DMAC7.html)
GB (1) GB2179936B (cg-RX-API-DMAC7.html)
GR (1) GR862055B (cg-RX-API-DMAC7.html)
HK (1) HK99691A (cg-RX-API-DMAC7.html)
HU (1) HU196602B (cg-RX-API-DMAC7.html)
IE (1) IE59222B1 (cg-RX-API-DMAC7.html)
IL (1) IL79608A (cg-RX-API-DMAC7.html)
IT (1) IT1197067B (cg-RX-API-DMAC7.html)
LU (2) LU88574I2 (cg-RX-API-DMAC7.html)
MY (1) MY102212A (cg-RX-API-DMAC7.html)
NL (1) NL8601991A (cg-RX-API-DMAC7.html)
OA (1) OA08672A (cg-RX-API-DMAC7.html)
PT (1) PT83134B (cg-RX-API-DMAC7.html)
SE (1) SE469633B (cg-RX-API-DMAC7.html)
SG (1) SG79791G (cg-RX-API-DMAC7.html)
SU (1) SU1516013A3 (cg-RX-API-DMAC7.html)
YU (1) YU45793B (cg-RX-API-DMAC7.html)
ZA (1) ZA865842B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959469A (en) * 1984-12-27 1990-09-25 Banyu Pharmaceutical Company, Ltd. Crystalline cephalosporin compounds
US4883868A (en) * 1984-12-27 1989-11-28 Banyu Pharmaceutical Co., Ltd. 7-amino-3-(substituted isoindolinium)methyl-3-cephem derivatives
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
DE3788279T2 (de) * 1987-06-25 1994-06-16 Banyu Pharma Co Ltd Kristalline cephalosporinzusammensetzungen, verfahren und zwischenprodukte für ihre herstellung.
JPH02101081A (ja) * 1988-10-08 1990-04-12 Meiji Seika Kaisha Ltd セファロスポリン誘導体結晶性二塩酸塩及びその製造法
CA2011116C (en) * 1989-03-06 1999-11-16 Murray A. Kaplan Lyophilized bmy-28142 dihydrochloride for parenteral use
CA2101571A1 (en) * 1992-09-08 1994-03-09 Elizabeth A. Garofalo Crystalline dihydrate of a cephalosporin dihydrate salt and injectable compositions thereof
DE69427469T2 (de) * 1993-03-12 2001-10-31 Pharmacia & Upjohn Co., Kalamazoo Kristallines ceftiofur (freie säure)
EP0638573A1 (en) * 1993-08-10 1995-02-15 Lucky Ltd. Crystalline hydrates of cephalosporin and process for preparation thereof
US7592447B2 (en) 2003-12-23 2009-09-22 Sandoz Ag Process for production of intermediates for use in cefalosporin synthesis
WO2008056221A2 (en) * 2006-11-06 2008-05-15 Orchid Chemicals & Pharmaceuticals Limited Crystalline sulfate salt of cephalosporin antibiotic
DE102012101680A1 (de) * 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
DE3419015A1 (de) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von cephalosporinen
GB8424692D0 (en) * 1984-10-01 1984-11-07 Glaxo Group Ltd Chemical compounds
GB2165245B (en) * 1984-10-01 1988-05-25 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
FR2585705B1 (fr) 1989-01-13
AT390957B (de) 1990-07-25
ATA211086A (de) 1990-01-15
HK99691A (en) 1991-12-13
BE905219A (fr) 1987-02-04
IE862078L (en) 1987-02-05
IL79608A (en) 1991-07-18
MY102212A (en) 1992-05-15
DD254941A5 (de) 1988-03-16
KR930003121B1 (ko) 1993-04-19
SE8603308L (sv) 1987-02-06
SG79791G (en) 1991-11-15
FI84484B (fi) 1991-08-30
DK371886D0 (da) 1986-08-04
DK162053B (da) 1991-09-09
ZA865842B (en) 1987-04-29
CH675581A5 (cg-RX-API-DMAC7.html) 1990-10-15
YU137186A (en) 1987-12-31
AR243894A1 (es) 1993-09-30
GR862055B (en) 1986-12-24
DK371886A (da) 1987-02-06
IT1197067B (it) 1988-11-25
FI84484C (fi) 1991-12-10
PT83134B (pt) 1989-07-31
IL79608A0 (en) 1986-11-30
JPS62103090A (ja) 1987-05-13
HUT41802A (en) 1987-05-28
SE8603308D0 (sv) 1986-08-04
DK162053C (da) 1992-02-10
NL8601991A (nl) 1987-03-02
LU88574I2 (fr) 1995-03-01
SE469633B (sv) 1993-08-09
FI863155A0 (fi) 1986-08-01
CA1284994C (en) 1991-06-18
LU86540A1 (fr) 1987-03-06
GB2179936A (en) 1987-03-18
IE59222B1 (en) 1994-01-26
FR2585705A1 (fr) 1987-02-06
CS276849B6 (en) 1992-08-12
AU597262B2 (en) 1990-05-31
CS276717B6 (en) 1992-08-12
EG18003A (en) 1991-08-30
IT8621409A0 (it) 1986-08-04
PT83134A (en) 1986-09-01
CY1614A (en) 1992-07-10
GB8618989D0 (en) 1986-09-17
DE3626375A1 (de) 1987-02-12
ES2002112A6 (es) 1988-07-16
FI863155A7 (fi) 1987-02-06
DD268395A5 (de) 1989-05-31
JPH0615548B2 (ja) 1994-03-02
KR880002530A (ko) 1988-05-09
GB2179936B (en) 1989-04-26
AU6069486A (en) 1987-02-12
SU1516013A3 (ru) 1989-10-15
HU196602B (en) 1988-12-28
IT8621409A1 (it) 1988-02-04
OA08672A (en) 1989-03-31

Similar Documents

Publication Publication Date Title
YU45793B (sh) Postupak za dobijanje stabilnih kristalnih adicionih soli 7-/alfa-(2-aminotiazola-4-il)-alfa-(z)-metoksiimino acetamido/-3-/(1-metil-1-pirolidino)-metil/-3-cefem-karboksilata sa kiselinama, kao i preparata koji ih sadrže
DE3752361D1 (de) Optisch aktive Pteridinderivate
ES2012948A6 (es) Procedimiento para la preparacion de sales de cefalosporina y composiciones inyectables
US3950223A (en) Stabilizing and enhancing urokinase activity
JPS54132592A (en) 3,7-di-substituted-3-cephem-4-carboxylic acid derivative, its salt, and their preparation
DK504384D0 (da) Stabil, vandig syreoploesning af cis-platin, egnet til injektion
NO132692B (cg-RX-API-DMAC7.html)
DE69419037D1 (de) Feste aminoxid-maleinsäure-salze enthaltende zusammensetzungen
DE69505389D1 (de) Rückgewinnung einer carbonsäure aus einer ein amin und ein extraktionsanreicherungsmittel enthaltenden lösung
BR9408563A (pt) Processo para a produção de formulações sólidas contendo tensoativos de óxido de amina
ES2132872T3 (es) Procedimiento de purificacion de diacetilreina.
KR870000237B1 (ko) 세라펩타제를 안정화 시키는 방법
PT93991A (pt) Processo para a preparacao de solucoes estaveis de analogos de rebecamicina
CA1128862A (en) Cephradine compositions and method
ATE1281T1 (de) Insulinkristallsuspension und verfahren zu ihrer herstellung.
SU1837586A1 (ru) Способ получения хлоридов калия и натрия из сильвинита
TNSN91036A1 (fr) 3'-deamino-4' deoxy-4'-amino-8-fluoro-anthracyclines et leur procede de fabrication
US3636201A (en) Accelerating the lysis of blood clots with urokinase and n-glycylpyrrolidine or salt thereof
Moriyama Studies on X-Agent VII. Time-Fluctuation of X-Agent
SU1586132A1 (ru) Способ получения тетрахлорпиколиновой кислоты
BE844403A (fr) Nouveaux derives d'acides (&-amino w (methylenedioxy-2,3 phenyl)acylamido)-7 cephalosporaniques, utiles notamment comme antibacteriens, et leur procede de preparation
MY116452A (en) Cephalosporin salts and injectable compositions
BE874622A (fr) Nouveaux derives d'acide 7-(amino(1,3-dihydrobenzo (c) thienyl) acetamido)-cephalosporanique, utiles notamment comme antibiotiques, et leur procede de preparation
Moriyama Studies on X-agent
JPS5686139A (en) P-hydroxyphenylglycine o-toluenesulfonate